2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities
The nonmetabolizable glucose analog 2-deoxy-D-glucose (2-DG) has shown promising pharmacological activities, including inhibition of cancerous cell growth and N-glycosylation. It has been used as a glycolysis inhibitor and as a potential energy restriction mimetic agent, inhibiting pathogen-associat...
Saved in:
Main Authors: | Raman Singh, Vidushi Gupta, Antresh Kumar, Kuldeep Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Advances in Pharmacological and Pharmaceutical Sciences |
Online Access: | http://dx.doi.org/10.1155/2023/9993386 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Which is the real nature of glucose‐dependent insulinotropic peptide?: Endogenous vs pharmacological
by: Yuji Yamazaki, et al.
Published: (2025-02-01) -
Ethnomedicinal, Pharmacological, and Phytochemical Overview of Diplazium esculentum
by: Abhishek Singh
Published: (2025-01-01) -
Chemistry and pharmacological diversity of quinoxaline motifs as anticancer agents
by: Ajani Olayinka O., et al.
Published: (2019-06-01) -
Pharmacology /
by: Rosenfeld, Gary C.
Published: (2007) - Pharmacology